Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity

被引:54
作者
Kothandapani, Anbarasi [1 ]
Gopalakrishnan, Kathirvel [2 ]
Kahali, Bhaskar [3 ]
Reisman, David [3 ]
Patrick, Steve M. [1 ]
机构
[1] Univ Toledo, Dept Biochem & Canc Biol, Toledo, OH 43614 USA
[2] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Physiol Genom Lab, Toledo, OH 43614 USA
[3] Univ Florida, Dept Med, Div Hematol & Oncol, Gainesville, FL 32610 USA
基金
美国国家卫生研究院;
关键词
Brg1; Brm; Chromatin remodeling; Cisplatin; NUCLEOTIDE EXCISION-REPAIR; SWI-SNF COMPLEX; NECK-CANCER; CELL-LINES; BRG1; P53; CHEMOTHERAPY; PROTEIN; HEAD; SENSITIVITY;
D O I
10.1016/j.yexcr.2012.06.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chromatin remodeling complex SWI/SNF plays important roles in many cellular processes including transcription, proliferation, differentiation and DNA repair. In this report, we investigated the role of SWI/SNF catalytic subunits Brg1 and Brm in the cellular response to cisplatin in lung cancer and head/neck cancer cells. Stable knockdown of Brg1 and Brm enhanced cellular sensitivity to cisplatin. Repair kinetics of cisplatin DNA adducts revealed that downregulation of Brg1 and Brm impeded the repair of both intrastrand adducts and interstrand crosslinks (ICLs). Cisplatin ICL-induced DNA double strand break repair was also decreased in Brg1 and Brm depleted cells. Altered checkpoint activation with enhanced apoptosis as well as impaired chromatin relaxation was observed in Brg1 and Brm deficient cells. Downregulation of Brg1 and Brm did not affect the recruitment of DNA damage recognition factor XPC to cisplatin DNA lesions, but affected ERCC1 recruitment, which is involved in the later stages of DNA repair. Based on these results, we propose that SWI/SNF chromatin remodeling complex modulates cisplatin cytotoxicity by facilitating efficient repair of the cisplatin DNA lesions. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:1973 / 1986
页数:14
相关论文
共 50 条
[1]   The ERCC1/XPF endonuclease is required for completion of homologous recombination at DNA replication forks stalled by inter-strand cross-links [J].
Al-Minawi, Ali Z. ;
Lee, Yin-Fai ;
Hakansson, Daniel ;
Johansson, Fredrik ;
Lundin, Cecilia ;
Saleh-Gohari, Nasrollah ;
Schultz, Niklas ;
Jenssen, Dag ;
Bryant, Helen E. ;
Meuth, Mark ;
Hinz, John M. ;
Helleday, Thomas .
NUCLEIC ACIDS RESEARCH, 2009, 37 (19) :6400-6413
[2]   Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells [J].
Arora, Sanjeevani ;
Kothandapani, Anbarasi ;
Tillison, Kristin ;
Kalman-Maltese, Vivian ;
Patrick, Steve M. .
DNA REPAIR, 2010, 9 (07) :745-753
[3]   Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells:: role of wild-type p53 and Bcl-XL [J].
Bauer, JA ;
Trask, DK ;
Kumar, B ;
Los, G ;
Castro, J ;
Lee, JSJ ;
Chen, JY ;
Wang, SM ;
Bradford, CR ;
Carey, TE .
MOLECULAR CANCER THERAPEUTICS, 2005, 4 (07) :1096-1104
[4]   BRCA1 is associated with a human SWI/SNF-related complex: Linking chromatin remodeling to breast cancer [J].
Bochar, DA ;
Wang, L ;
Beniya, H ;
Kinev, A ;
Xue, YT ;
Lane, WS ;
Wang, WD ;
Kashanchi, F ;
Shiekhattar, R .
CELL, 2000, 102 (02) :257-265
[5]   Characterization of mammary tumors from Brg1 heterozygous mice [J].
Bultman, S. J. ;
Herschkowitz, J. I. ;
Godfrey, V. ;
Gebuhr, T. C. ;
Yaniv, M. ;
Perou, C. M. ;
Magnuson, T. .
ONCOGENE, 2008, 27 (04) :460-468
[6]   THE SNF/SWI FAMILY OF GLOBAL TRANSCRIPTIONAL ACTIVATORS [J].
CARLSON, M ;
LAURENT, BC .
CURRENT OPINION IN CELL BIOLOGY, 1994, 6 (03) :396-402
[7]   Trends in incidence and prognosis for head and neck cancer in the United States: A site-specific analysis of the SEER database [J].
Carvalho, AL ;
Nishimoto, IN ;
Califano, JA ;
Kowalski, LP .
INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (05) :806-816
[8]   Distinct roles for the RSC and Swi/Snf ATP-dependent chromatin remodelers in DNA double-strand break repair [J].
Chai, B ;
Huang, J ;
Cairns, BR ;
Laurent, BC .
GENES & DEVELOPMENT, 2005, 19 (14) :1656-1661
[9]   Defining the function of XPC protein in psoralen and cisplatin-mediated DNA repair and mutagenesis [J].
Chen, ZW ;
Xu, XXS ;
Yang, J ;
Wang, G .
CARCINOGENESIS, 2003, 24 (06) :1111-1121
[10]   Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy [J].
Clingen, P. H. ;
Wu, J. Y. -H. ;
Miller, J. ;
Mistry, N. ;
Chin, F. ;
Wynne, P. ;
Prise, K. M. ;
Hartley, J. A. .
BIOCHEMICAL PHARMACOLOGY, 2008, 76 (01) :19-27